Free tool
FAERS Monitor: Sephience
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 219666 or its brand name (Sephience, Sepiapterin). Reports on generic versions are filed under their own applications.
Reports
190
Serious
21
11% of reports
Hospitalization
5
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- product preparation issue55
- drug ineffective19
- diarrhoea16
- abdominal discomfort10
- amino acid level increased10
- tooth discolouration10
- vomiting10
- abdominal pain upper8
- headache7
- skin discolouration7
- nausea6
- product preparation error6
- retching6
- abdominal pain5
- flatulence5
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2025 | 4 |
| 2026 | 186 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,969 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| amino acid level increasedSignal | 10 | 1511.7 | 823.4 | 13,442 |
| product preparation issueSignal | 55 | 936.0 | 748.1 | 50,035 |
| tooth discolourationSignal | 10 | 377.7 | 206.4 | 3,379 |
| product preparation errorSignal | 6 | 32.3 | 14.7 | 152 |
| retchingSignal | 6 | 31.2 | 14.2 | 146 |
| skin discolourationSignal | 7 | 16.9 | 8.2 | 89 |
| flatulenceSignal | 5 | 9.8 | 4.1 | 31 |
| abdominal discomfortSignal | 10 | 6.6 | 3.6 | 42 |
| abdominal pain upperSignal | 8 | 4.3 | 2.2 | 17 |
| diarrhoeaSignal | 16 | 2.7 | 1.7 | 17 |
| abdominal pain | 5 | 2.4 | 1.0 | 3 |
| vomitingSignal | 10 | 2.4 | 1.3 | 7 |
| drug ineffective | 19 | 1.6 | 1.0 | 4 |
| headache | 7 | 1.2 | 0.6 | 0 |
| nausea | 6 | 0.8 | 0.4 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.